The authors undertook an observational, clinical study to explore the feasibility and potential clinical benefits of an upfront approach to the genomic profiling of tumors from metastatic colorectal cancer (mCRC) patients.
  

Feasibility Study of Genomic Biomarker Profiling for Patients with Metastatic Colorectal Cancer